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Astrocytes provide an optimal surface for attachment, migration, and growth of CNS neurons.
Nonetheless, not all astrocytes are alike: our previous work demonstrated a heterogeneity in the ability of cultured astrocyte monolayers to support neuronal growth. Areas displaying a fibrous, uneven surface ("rocky" astrocytes) were shown to be restrictive substrates, whereas surrounding, flat areas were permissive substrates.
However, whether these cell types are in fact different cannot be addressed using mixed cultures. Therefore, in the current study we used morphological criteria to isolate the two subpopulations from mixed astrocyte cultures established from the cerebral cortex of neonatal rats. Following isolation, the purified populations only produced progeny with the same phenotype as the parent cells. We then measured production of several extracellular matrix molecules putatively involved in neuronal guidance during development and quantitatively assessed neuronal behavior on the purified populations.
Immunocytochemistry and immunoblotting showed that rocky astrocytes were enriched in tenascin and chondroitind-sulfate-containing proteoglycans, but not in laminin or fibronectin. In addition, these astrocytes, as well as their isolated matrix, were a less permissive substrate for neuronal growth than flat astrocytes/matrix.
Neurite outgrowth was significantly increased on rocky astrocytes following treatment with chondroitinase ABC or AC, but not heparitinase or hyaluronidase.
These data support a critical role for matrix-bound chondroitin-6-sulfate-containing proteoglycans. We hypothesize that rocky astrocytes represent a subtype of cells which form barriers to neuronal growth during cortical development.
[Key words: tenascin, chondroitin sulfate proteoglycan, extracellular matrix, astrocyte/neuron interactions, development, regeneration] Interactions between neurons and glia shape CNS development. The major classes of macroglia, oligodendrocytes and astrocytes, are biochemically and functionally distinct. Oligodendrocytes synthesize myelin and related proteins, and their function appears to be the ensheathment of neurons to increase the velocity of nerve conduction (Mirsky et al., 1980; Raff, 1989) . Astro-cytes are characterized by their expression of glial fibrillary acidic protein (GFAP) (Bignami et al., 1972) , and their function is still a matter of active interest. Early in development, astrocytes shape neuronal migration and neurite outgrowth (Rakic, 1971; Silver et al., 1982) , providing both positive and negative pathfinding cues (Pindzola et al., 1993) . In the adult, mature astrocytes may provide trophic support for continued neuronal survival and may even inhibit additional growth (Fawcett et al., 1989; Smith et al., 1990) .
The diverse functions of astrocytes are likely to reflect further heterogeneity in the astrocyte population. Even within the same brain region, astrocytes exhibit differences in neurotransmitter uptake (Johnstone et al., 1986) and expression of receptors (Trimmer and McCarthy, 1986) , surface glycoproteins (Barbin et al., 1988; Vaysee and Goldman, 1992) , and extracellular matrix (ECM) molecules (Crossin et al., 1986; Pindzola et al., 1993) . Astrocytes are also morphologically heterogeneous: early in vivo studies defined fibrous and protoplasmic astrocytes, found mainly in white or grey matter, respectively (Ramon y Cajal, 1909; Peters et al., 1991) . Astrocytes in culture also exhibit morphological, as well as antigenic, diversity, for example, type-l and type-2 astrocytes (Raff et al., 1983) . Other studies have demonstrated five morphologically distinct types of astrocytes in rat spinal cord cultures (Miller and Szigeti, 1991) .
Our work has demonstrated heterogeneity in type-l astrocytes both in terms of morphology and ability to support neuronal growth. Embryonic neurons will avoid a subpopulation of astrocytes (termed "rocky") that is characterized by a fibrous, uneven morphology and increased tenascin expression; neurons grow well on surrounding flat astrocytes (Grierson et al., 1990) . However, whether these cell types are in fact unique cannot be addressed using mixed cultures. To address this question in the current study, we isolated the astrocyte populations from mixed monolayers, measured their production of several molecules thought to be involved in neuronal guidance during development, and quantitatively assessed the behavior of neurons on the purified populations. Cells were separated by morphoJogica1 criteria, dissociated, plated at low density, and grown to confluence. The confluent cultures retained the distinctive phenotypes of the parent cells. As in mixed monolayers, rocky astrocytes contained elevated levels of tenascin and similar levels of laminin and fibronectin; they were also found to contain elevated levels of chondroitin-6-sulfate-containing proteoglycans (CS-6-PG) and were poor substrates for neuronal adhesion and process extension. These properties strongly resemble those of the boundary-forming astrocytes that provide negative cues for neurite growth during development in vivo (Pindzola et al., 1993) .
Neurite outgrowth on rocky astrocytes was significantly enhanced following chondroitinase treatment; however, flat astrocytes were still a more permissive substrate. Similar to living cells, neurite outgrowth was less robust on rocky as opposed to flat matrix. Rocky astrocytes therefore exhibit a constellation of properties that negatively impact on neuronal development and regeneration and provide a model system for assessing the relative contributions of tenascin, CS-6-PG, and other ECM components in these processes.
Materials and Methods
Materials. Sprague-Dawley rats were purchased from Charles River Breeding Laboratories, Inc. (Wilmington, MA). Basal Media Eagle (BME), Dulbecco's Modified Eagle's Medium (DMEM), and fetal calf serum (FCS) were purchased from GIBCO Laboratories (Grand Island, NY). Antisera against human tenascin, rat fibronectin, and cow GFAP were obtained from GIBCO-BRL (Gaithersbura, MD), Chemicon (Temecula, CA), and DAK0 Corp. (Carpinteria, CA), respectively. Monoclonal antibodies against 6-sulfated or 4-sulfated chondroitin or dermatan sulfate stubs of chondroitinase ABC-digested human proteoglycans were purchased from ICN Biomedicals (Costa Mesa, CA). Monoclonal antibodies against mouse GFAP and affinity isolated antibody against mouse laminin were purchased from Sigma Chemical Co. (St. Louis, MO). Nitroblue tetrazolium and 5bromo-4-chloro-3-indoylphosphate were obtained from Kirkegard and Perry Laboratories Inc. (Gaithersburg, MD). Chondroitinase ABC, chondroitinase AC, heparitinase, and hyaluronidase (hyaluronoglucosidase) were obtained from ICN Biomedicals. All other chemicals and supplies were purchased from Sigma Chemical Co., Bio-Rad Laboratories (Richmond, CA) or Fisher Scientific (Springfield, NJ). Astrocyte cell culture. Rat cerebral cortical astrocytes were prepared according to a method adapted from McCarthy and de Vellis (1980) . Cerebral cortices from postnatal day 1 Sprague-Dawley rats were removed and placed into BME with 0.02 M HEPES buffer. The meningeal tissue and as much white matter as possible was removed. The remaining tissue was finely minced with dissecting knives and then trypsintreated (0.025%) for 20 min. The cells were pelleted by centrifugation at 1000 rpm for 5 min and resuspended in 5 ml of serum-containing medium comuosed of DMEM suuolemented with 10% FCS and 2.2 mg/ml NaHCb3. One milliliter of 6:025% soybean trypsin inhibitor and 0.05% DNase was added to the mixture, and the tissue was triturated several times through a fire-polished Pasteur pipette. The cell solution was passed through a fine nylon mesh and placed into 80 cm2 poly-ilysine (PLL)-coated culture flasks at a final density of from 2 to 4 X IO6 cells/flask. Once the astrocytes reached confluence (approximately 10 d to 2 weeks), the flasks were shaken overnight on a rotary shaker to remove loosely adherent, contaminating top cells (oligodendrocytes, neurons, and macrophages). Astrocytes are routinely screened via immunofluorescence techniques for the expression of GFAP as well as for oligodendrocyte and neuronal markers, and this culture method generally yields >95% GFAP-positive cells.
As cultures with particularly pronounced, and distinct, flat and rocky areas were identified, these areas were carefully removed from the flask with a sterile spatula, trypsinized, and triturated to form a single cell suspension. Astrocytes then were replated onto PLL-coated 12 mm round glass coverslips in 24.well trays at low density (l-2 X lo2 cells/ well) for immunocytochemistry assays or at medium density (l-2 X lo2 cells/well) for neurite outgrowth assays. Other astrocytes were replated at medium density (2-3 X lo3 cells/well) in PLL-coated 12-well trays for Western blotting or onto PLL-coated 13 mm2 etched grid coverslips (Bellco Glass Inc., Vineland, NJ) in 12.well trays for neuronal adhesion assays.
Neuronal Eel1 culture. Hypothalamic and mesencephalic neuronal cultures were oreoared as described bv Ventimiglia and Geller (1987) . Hypothalamic&nenrons were chosen for this study because they were the type of neuron used in the original work describing rocky astrocytes (Grierson et al., 1990) . Mesencephalic neurons were chosen because we wished to determine whether the growth restrictive effects extended to more than one type of neuron. Embryonic rats were isolated from timedpregnant females by caesarian section. The appearance of a sperm plug was defined as embryonic day 1 (El); neuronal cultures were cultivated between El4 and E18. Embryonic brains were removed into a Petri dish containing 5 ml of BME-HEPES. Meninges were peeled off, and selected brain regions (hypothalamus; mesencephalon) were removed and minced into fine pieces (<0.5 mm) with dissecting knives. Any remaining meninges and blood vessels were removed at this time to ensure minimal contamination from endothelial cells. The minced tissue was then incubated in BME-HEPES containing 0.025% trypsin and 0.1% collagenase for 30 min at 37°C. Following incubation, the trypsinization was halted bv adding 1 ml of DMEM/IO% FCS containing 0.025% soy bean trypsin inhibi'ior and 0.05% DNAse I. The tissue was then gently triturated through a fire-polished Pasteur pipette until it was dispersed into a homogeneous suspension. The suspension was filtered through a fine nylon mesh (40 pm, Tetko) and centrifuged for 5 min at 1000 'pm. The pellet of embryonic cells was resuspended in fresh serum-containing medium and used for neuronal adhesion and neurite outgrowth assays as described below.
Identijcation of extracellular matrix molecules and GFAP in astrocyte extracts.
Astrocytic tenascin, chondroitin-6-sulfate-containing proteoglycans (CS-6-PC), chondroitin-4-sulfatecontaining proteoglycans (CS-4-PG), fibronectin, laminin, and GFAP were identified using immunoblotting techniques. The CS-6.PG antibody recognizes chondroitin-6-sulfate stubs of high density proteoglycans following a 1 hr incubation of cells with 0.1 U/ml chondroitinase ABC at 37°C; the CS-4.PG antibody recognizes chondroitin-4.sulfate or dermatan sulfate (DS) stubs. Astrocyte cultures were removed from 12-well chambers by aspirating off the media, rinsing the cells with 0.5 M ethylenediaminetetraacetate (EDTA), and scraping the cells into 150 pl of Laemmli sample buffer (Laemmli, 1970 ) using a rubber policeman. Protein concentrations were determined using the Bio-Rad-DC protein assay. Cell extracts (20 p,g) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) and then transferred to nitrocellulose paper (400 mA, 1.5 hr) (Towbin et al., 1979) . The blots were incubated in blocking solution containing 5% dry milk (Carnation brand) in Tris-buffered saline (TBS: 20 mM Tris-HCl pH 7.5, 0.5 M NaCl) for 2Z4 hr. They were then incubated overnight in a solution of the appropriate primary antibody (rabbit anti-tenascin, mouse anti-CS-4-PG, mouse anti-CS-6-PG, rabbit anti-fibronectin, rabbit anti-laminin, or rabbit anti-GFAP) diluted 1 :lOOO (1:200 for anti-CS-4-PG and anti-CS-6-PG) in 3% drv milkfIBS and washed. The washing procedure consisted of four 10 'min washes in TBS containing 0.05% Tween 20. The blot was then incubated with alkaline phosphatase-conjugated goat anti-rabbit or goat anti-mouse IgG (Sigma Chemical Co.) at a 1:000 dilution and washed as above. Bound tenascin, tibronectin, or laminin antibody was detected calorimetrically using 5-bromo-4-chloro-3-indoyl-phosphate and nitroblue tetrazolium. All antibody incubations and washes were done at room temperature.
QuantiIcation of tenascin and GFAP production.
The relative intensities of the tenascin and GFAP bands in purified cultures were compared and quantified as we have described previously (Meiners et al., 1993) . Immunoblots were scanned at 600 dots per inch and 256 gray scale resolution on a Microtek 600G scanner. Images were analyzed using the NIH IMAGE program (available by anonymous FTP from zippy.nimh.nih.gov) with the Gel Analysis Macro routine. A profile of intensities of immunoreactivity within each lane was first created and used as an indication of the level. of tenascin or GFAP production. Immunoblots containing serial dilutions of cell extracts were also scanned, and the intensity values were found to increase with increasing volumes of cell extract. Within each gel. the levels of tenascin or GFAP expression in rocky astrocytes were normalized to the level in flat cultures, which was assigned a value of 1. Only astrocytes from the same parent culture were compared to each other in these experiments. The data from several independent experiments was then pooled and analyzed using the INSTAT program (GraphPad Software, La Jolla, CA).
Immunojhorescence analysis. Astrocyte cultures were double-labeled with rabbit polyclonal antiserum against tenascin and monoclonal antibody against GFAP or with monoclonal antibody against CS-6-PG and polyclonal antiserum against GFAP For CS-6-PG labeling, astrocytes were first digested with chondroitinase ABC as described above for CS-6.PG immunoblots. Fluorescently conjugated secondary antibodies were obtained from Organon-Technika Cappel. Cell cultures on glass coverslips in 24.well chambers were incubated with anti-tenascin or anti-CS-6-PG diluted 1:lOO in phosphate-buffered saline (PBS: 0.14 M NaCl, 2.7 mM KCl, 1.5 mM KH,PO,, 4.3 mM NaHPO,) containing 0.1% sodium azide (PBS-azide) and 10% FCS (PBS azide-serum) for 30 min at 4°C. After rinsing in PBS-azide, the coverslips were incubated with fluorescein-conjugated secondary antibodies (goat anti-rabbit for tenascin and goat anti-mouse for CS-6-PG) diluted 1:lOO in PBS azide-serum for 30 min at 4°C. The astrocytes were again rinsed in PBS-azide and fixed by submerging the coverslips in acetic acid/ethanol (5%/95%) for 5 min at -20°C. After rinsing in PBS-azide-serum, the incubation and rinse steps were then repeated using monoclonal mouse anti-GFAP and rhodamine-conjugated goat anti-mouse secondary antibody (Organon-Technika Cappel) for the anti-tenascin-labeled coverslips and polyclonal anti-GFAP and rhodamine-conjugated goat anti-rabbit secondary antibody for the anti-CS-6-PC-labeled coverslips. After the final incubation,'coverslips were rinsed in PBS-azide and mounted in Citifluor (City of London Polytechnic) on microscope slides. Nonspecific binding of secondary antibodies was controlled for by omitting the appropriate primary antibody i n parallel cultures. Cultures were examined using a Zeiss Axioplan microscope equipped with an epifluorescence illuminator with fluorescein and rhodamine filters. Photographs were taken using Kodak TMAX 400 film.
Neuronal adhesion assays. Neuronal adhesion assays were conducted as described in our previous work (Petroski et al., 1991) . Embryonic day 17 (E17) hypothalamic or El5 mesencephalic cells were plated at 20,000 cells/well onto astrocyte monolayers grown on etched grid coverslips in 12-well chambers. The cells were allowed to settle and adhere for I hr. Cultures were then shaken at 75 rpm on a horizontal rotating platform in a 37°C incubator for 60 min, rinsed four times with fresh medium, and then fed. At 48 hr cultures were incubated with the dye carboxyfluorescein diacetate (CFDA) (I 0 kg/ml) for 30 min at 37°C and rinsed for an additional 30 min with medium. Under these conditions only viable neurons retain the dye and exhibit fluorescence (Grumet et al., 1983; Petroski and Geller, 1994) . Coverslips of living cells were examined under fluorescein optics, and CFDA-labeled neurons were counted in nonoverlapping fields (equivalent to approximately 15 mm*) of the coverslip.
Neurite outgrowth assays. Dissociated El5 mesencephalic cells were plated onto astrocyte monolayers at 10,000 cells/well in 24.well chambers. Coverslips were labeled with CFDA 24,48, and 72 hr after plating. CFDA intensely stains the soma and all processes of cultured, living neurons. Images of the cultures were captured using a Macintosh Quadra 700 with a Scion LG-3 frame grabber board and analyzed with the NIH IMAGE software. The length of each primary process and its branches was measured for at least 50 neurons for each condition. The total neuritic length for each neuron was calculated as the sum of the lengths of individual neurites.
Enzymutic treatment of astrocyte monolayers.
Astrocytes in 24.well chambers were treated with either chondroitinase ABC, chondroitinase AC, heparitinase, or hyaluronidase/hyaluronoglucosidase.
[Chondroitinase ABC degrades chondroitin-6-sulfate (CS-6), chondroitin4sulfate (CS-4), and dermatan sulfate (DS) to 4Junsaturated disaccharides by elimination. Chondroitinase AC degrades CS-6 and CS-4 but not DS. Heparitinase catalyzes the eliminative cleavage of heparan sulfate but also has slight chondroitinase activity. Hyaluronidase specifically cleaves hyaluronic acid. For a more detailed description of the specifications of these enzymes, see the ICN product analysis sheets.] After aspirating off the culture media, the astrocytes were covered with one of the following enzyme solutions for 4 hr at 37°C: (1) chondroitinase ABC, 0.1 unit/ml, in 0.1 M Tris acetate buffer, pH 8.0; (2) chondroitinase AC, 0.1 unit/ml in 0.1 M Tris acetate buffer, pH 7.3; (3) heparitinase, 1 unit/ml in 0.1 M PBS, pH 7.3; or (4) hyaluronidase, 5 units/ml in 0.1 M Na acetate buffer, pH 5.0. The enzyme solution was removed and replaced with fresh media. El5 mesencephalic cells were plated onto the enzyme-treated astrocytes at a density of 10,000 cells/well and processed for neurite outgrowth assays 24 and 48 hr after plating.
Growth qf' neurons on extracellular matrix.
Matrices were prepared from cultures grown in 24-well chambers according to the methods of Smith-Thomas et al. (1994) . Briefly, confluent cells were washed twice with Hanks' balanced salts solution and treated with distilled water containing 0.2% Triton X-100 twice for 20 min; the cellular debris was then vigorously washed away with a Pasteur pipette. The matrix preparations were washed twice with distilled water. El5 mesencephalic cells were plated onto the matrix in serum-containing medium at a density of 10,000 cells/well. Cultures were processed for neurite outgrowth assays 24 and 48 hr after plating.
Results

Isolation qf astrocyte subpopulations from mixed monolayers
Cerebral cortical astrocytes were cultivated from neonatal rats, and flat and rocky areas of heterogenous monolayers were identified. Figure 1A depicts a typical rocky clump of cells, similar to those described by Grierson et al. (1990) , surrounded by flat cells. The rocky areas are generally fairly small as shown, although they do vary in size from only a few cells to several millimeters in diameter. As particulary pronounced rocky and flat regions arose, these were subcultured onto PLL-coated coverslips in 10% serum-containing medium at l-2 X lo2 cells/well as described in Materials and Methods.
Astrocytes subcultured at l-2 X lo2 cells/well were plated down as distinct single cells so as to disrupt any homotypic epigenetic signaling potentially required to maintain one form or the other that may have been provided by cells remaining in sheets or clumps. After reaching confluence, the flat cells continued to demonstrate a flat morphology (Fig. 1B) whereas the rocky cells demonstrated a fibrous, uneven morphology (Fig.  1C) . The fact that the astrocyte populations maintain their phenotypic differences after replating suggests that they may represent different subtypes of glial cells, as opposed to, for example, different stages of astrocyte maturity.
While subculturing astrocytes at this low density allowed us to follow the fate of individual cells, the cells grew very slowly and required up to two months to reach confluence. Therefore, we grew astrocytes at a density of l-2 X lo* cells/well for immunofluorescence experiments and at a density of 1-2 X IO3 cells/well for experiments requiring larger amounts of biological material (e.g., SDS-PAGE and immunoblot analysis, neuronal adhesion and neurite outgrowth assays). However, rocky astrocytes did grow more rapidly than flat astrocytes (data not shown). This distinguishes them from type-2 astrocytes, which have a low proliferative activity (Raff et al., 1983) , as does the fact that they lack A2B5, the type-2 astrocyte marker (Eisenbarth et al., 1979 ) (data not shown).
Production of tenascin, CS-6-PG, CS-4-PG, jibronectin, laminin, and GFAP Cell extracts from flat and rocky astrocytes were separated on SDS-PAGE gels, transferred to nitrocellulose paper, and probed with tenascin antiserum. The immunoblot with tenascin antiserum revealed three polypeptide bands for both extracts with M, 190,000, 200,000, and 240,000 (Fig. 2) , which is in agreement with the subunit molecular weights previously reported for rat tenascin (Chiquet-Ehrismann et al., 1986; Meiners et al., 1993) . Immunoblot analysis showed that all three tenascin isoforms were increased for rocky astrocytes. Immunoblots were analyzed by quantitative scanning densitometry. Tenascin production was increased an average of 4%fold and varied between 3.4-and 7.6-fold in five independent experiments (Fig. 3A) . This experimental variation was probably due in part to the technical difficulty involved in obtaining pure populations of astrocytes by morphological criteria, or, alternatively, suggests that there may be several subclasses of "rocky" astrocytes with varying amounts of tenascin.
CS-6-PG and CS-4-PG production were also examined on immunoblots. Following digestion with chondroitinase ABC, astrocytes were extracted, electrophoresed on SDS-PAGE gels, transferred to nitrocellulose paper, and probed with a monoclonal antibody against CS-6-PG or CS4-PG (Fig. 2) . Rocky extracts demonstrated three polypeptide bands that cross-reacted with the CS-6-PG antibody with IV, 148,000, 246,000, and 388,000 whereas no bands were detected in flat extracts. In addition, no bands were detected in extracts of undigested cells (data not shown). The relative intensities of the three bands varied from Figure 1 . Isolation of flat and rocky populations of cultured rat cerebral cortical astrocytes from a heterogenous monolayer. A, Nomarski differential contrast optics depicting a confluent culture with a distinct rocky region (middle left) surrounded by a flat region. These regions were dissected out of the monolayer with a sterile spatula, trypsinized and triturated into a single-cell suspension, and replated on 12 mm glass coverslips. The flat cells remained flat after reaching confluence (B), and the rocky cells remained rocky (C). This suggests that the subpopulations represent two distinct phenotypes under the conditions of our cell culture system. Scale bar, 10 pm. Figure 2. Immunoblot analysis of tenascin, CS-6-PG, CS-4-PG, fibronectin, laminin, and GFAP production. Cell extracts were resolved on SDS-PAGE gels (6% acrylamide for ECM molecules, 12% acrylamide for GFAP), transferred to nitrocellulose paper, and probed with the appropriate primary antibody. Cells were digested with chondroitinase ABC prior to extraction for CS-6-PG and CS-CPG immunoblots. Antibody binding was visualized using alkaline phosphatase-conjugated secondary antibodies (Sigma Chemical Co.) according to the manufacturer's instructions. Rocky astrocytes demonstrated increased amounts of tenascin, CSd-PG, and GFAP in comparison to flat astrocytes and similar amounts of fibronectin, laminin, and CS-CPG.
experiment to experiment. The M, 148,000 and 246,000 bands probably correspond to the ID1 CS-6-PG proteoglycans (with M, 150,000 and 245,000) reported in 7 d old rat brain by Rauch et al. (1991) . Cloning studies (Rauch et al., 1992) have revealed that the smaller 1Dl proteoglycan is apparently derived from the larger, termed neurocan, via proteolytic processing. The M, 388,000 band probably corresponds to the 3F8 proteoglycan (with M, 400,000), also reported in 7 d old rat brain by Rauch et al. (1991) . On the other hand, the CS-4-PG antibody failed to detect any cross-reactive bands in either flat or rocky extracts. As a positive control, the antibody did react with a polypeptide of M,. 200,000 in extracts of Neu7 cells (data not shown). Neu7, an immortalized astrocytic cell line, has been reported to express a dermatan sulfate-containing proteoglycan (DSPG) (Smith-Thomas et al., 1994) . We also investigated the production of fibronectin and laminin via immunoblotting techniques (Fig. 2) . Fibronectin antiserum reacted with a polypeptide of M, 230,000 for both astrocyte sub- Figure 3 . Quantification of tenascin and GFAP production. Tenascin and GFAP were visualized on immunoblots as in Figure 2 . Immunoblots were scanned and the level of tenascin or GFAP in each lane was quantified and normalized to the level in flat cultures, which was assigned a value of 1. Bars represent mean (n = 5) i-the SE and were statistically significant (Student's t test, p < 0.05).
types. Laminin antibody reacted with a polypeptide band of IV, 2 15,000, which corresponds to the B 1 chain of laminin. Laminin antibody occasionally reacted with a second polypeptide of IV, 205,000, which corresponds to the B2 chain of laminin (data not shown). Levels of fibronectin and laminin did not appear to vary greatly between flat and rocky astrocytes, confirming our previous immunocytochemical observations (Grierson et al., 1990 ) on mixed cultures. Our previous work showed that flat and rocky astrocytes in mixed monolayers also exhibited similar levels of the neurite outgrowth-promoting molecules thrombospondin and NCAM (Bixby et al., 1988; O'Shea et al., 1990; Neugebauer et al., 1991) ; early experiments demonstrate that this is true for isolated subpopulations as well (data not shown). Thus, the composition of the rocky matrix seems to be altered such that it is specifically enriched in negative regulators of neuronal growth while levels of positive regulators remain unchanged. Of course, the rocky matrix may also be deficient in levels of as yet unidentified positive regulators that are present in the flat matrix.
Finally, GFAP production was examined on immunoblots to confirm the identity of flat and rocky cells as astrocytes. GFAP antiserum reacted with a polypeptide of M, 49,000 for both cell extracts. Scanning densitometry demonstrated that GFAP expression was increased an average of 2.2-fold for rocky astrocytes and varied between 1.4-and 2%fold in five independent experiments (Fig. 3B) .
Immunocytochemistry of tenascin and CS-6-PG
To evaluate whether the increasing tenascin and CS-6-PG production was reflected as an increase in cell-surface protein, astrocytes were double-labeled with antibodies against tenascin and GFAP (Fig. 4) or CS-6-PG and GFAP (Fig. 5) . The tenascin staining was performed on living, unfixed cultures, while the GFAP staining was done after fixation and permeabilization.
CS-6-PG staining was performed on living, unfixed cultures following digestion with chondroitinase ABC. The flat astrocytes showed a fairly low level of both tenascin (Fig. 4E ) and CS-6-PG (Fig. 5E ) immunoreactivity.
Rocky astrocytes demonstrated a much higher level of immunoreactivity for both proteins (Figs.  4F, 5F ). In contrast, when flat and rocky astrocytes were labeled with antibodies against CS4-PG, little if any immunoreactivity was detected for either type of astrocyte (data not shown). The differences in tenascin and CS-6-PG levels were also found in mixed monolayers (data not shown). Note that the nuclei of rocky astrocytes were smaller (Figs. 4B , 5B) than the nuclei of flat astrocytes (Figs. 4A, 5A ), an observation also made by Grierson et al. (1990) for mixed monolayers. Immunoreactivity for tenascin and CS-6-PG was punctate in appearance and restricted to areas of the cellular periphery, as is typical for extracellular matrix proteins. These results therefore paralleled those obtained via immunoblot analysis and also confirmed that the tenascin antiserum and CSd-PG antibodies recognized appropriately localized antigens. Morphological differences between flat and rocky cultures were made more obvious by GFAP staining (Figs.  4C,D, 5C,D) . The rocky cultures depicted here were grown until nearly but not quite confluent (compare to fully confluent cultures in Fig. 1C ) so as to more readily distinguish individual cells. The amount of tenascin and CS-6-PG did not appear to be correlated with the confluence of the cultures in that more or less confluent cultures did not express higher or lower amounts of these proteins (data not shown).
Neuronal adhesion assays
A recent study in our laboratory (Petroski et al., 1991) demonstrated that the differentiation of astrocytes by bFGF reduced their ability to support the adhesion and survival of hypothalamic neurons by about 7.7-fold. This reduction in neuronal adhesion may have been due in part to high levels of astrocytic tenascin and CS-6-PG which are induced by bFGF (Meiners et al., 1993) . To evaluate whether neuronal adhesion was also reduced on tenascinKS-6-PG-rich rocky astrocytes, dissociated E 17 hypothalamic or El5 mesencephalic neurons were plated onto confluent monolayers of flat and rocky astrocytes grown on gridded coverslips. An adhesion assay was performed as described in Materials and Methods to evaluate specific neuronal attachment to the astrocyte substrate. Neuronal numbers were assessed at 48 hr by counting CFDA-labeled cells bound to nonoverlapping fields of the coverslip in each of four separate experiments. Only process-bearing cells were counted on the flat astrocyte substrate. Because a large percentage of the neurons did not generate neurites on the rocky substrate (see below), all of the CFDA-labeled cells with an appropriate soma size were counted. Rocky astrocytes demonstrated a reduced ability to support neuronal adhesion in comparison to flat astrocytes (Fig. 6 ). There was an equivalent significant reduction in adhesion of both hypothalamic and mesencephalic neurons on rocky versus flat astrocytes (p < 0.05, two-way analysis of variance). The fact that neurons from two different brain regions behaved similarly on the astrocyte substrates suggests that the differential adhesion to the flat and rocky substrates is due to intrinsic properties of the astrocytes rather than to intrinsic properties of the neurons.
Neurite extension on astrocyte monolayers Dissociated El 5 mesencephalic cells were plated onto confluent monolayers of flat and rocky astrocytes and labeled with CFDA after 24, 48, or 72 hr. Extensive neurite outgrowth occurred on flat monolayers at 24 hr (Fig. 7A) , while neurons aggregated and extended few, if any, processes on rocky monolayers (Fig. 7B) . After 48 hr neurons extended some processes on the rocky substrate (Fig. 70) ; however, these were shorter than those extended on flat monolayers (Fig. 7C) . A sizeable number of the neurons were still without neurites at this point. Neurites continued to extend on the flat substrate at 72 hr (Fig. 7D ), whereas they were not much longer on the rocky substrate than at 48 hr ( Fig. Figure 4 . Immunocytochemistry of tenascin and GFAP Living flat (A, C, E) and rocky (& D, F) cultures were immunostained with polyclonal antibodies against tenascin followed by a fluorescein-conjugated secondary antibody, fixed, and reacted with monoclonal antibodies against GFAP followed by a rhodamine-conjugated secondary antibody. Photomicrographs illustrate Nomarski differential contrast optics (A, B), GFAP immunoreactivity (C, D), and tenascin immunoreactivity (E, F). Rocky astrocytes demonstrated significantly higher levels of tenascin and somewhat higher levels of GFAP than flat astrocytes. Scale bar, 10 pm. Because a very small number of the neurons had processes on the rocky substrate after 24 hr, we analyzed the ability of each astrocyte population to support neurite generation at 24, 48, and 72 hr (Fig. 8) . At least 200 neurons were counted for each condition in three independent experiments. Neurites were defined as processes longer than one cell soma diameter. After 24 hr only 7% of cells extended neurites on the rocky astrocytes, versus 78.3% of the cells on flat astrocytes. These numbers increased to 58.3% and 68.2% on rocky astrocytes versus 87.4% and 93.4% on flat astrocytes 48 and 72 hr, respectively. Neurite generation was therefore impaired on rocky astrocytes in comparison to flat astrocytes. This could be attributed to either the production of more or different inhibitory molecules (including but not limited to tenascin and CS-6-PG) by rocky astrocytes, or, alternatively, to the production of more or different growthpromoting molecules by flat astrocytes.
Neurite outgrowth studies were conducted for neurons that did extend processes longer than one cell soma diameter. Neurons were cocultured with monolayers of flat or rocky astrocytes for 24, 48, or 72 hr, at which time the extent of neurite outgrowth was determined. Neurite outgrowth studies were not conducted on rocky astrocytes at 24 hr due to the paucity of neurons with neurites. We examined two parameters: the length of the longest neurite, and the combined length of all the neurites. Outgrowth values were plotted as cumulative histograms of the length of the longest neurite (Fig. 9A) or the total neuritic length (Fig.   9B) . A curve shifted to the right indicates that the neurites were longer for the entire population.
Most of the outgrowth on the flat astrocytes occurred during the first 48 hr with less outgrowth between 48-72 hr (Fig. 9) . The median length of the longest neurite for neurons grown on flat astroctytes was 60 pm at 24 hr; this value increased to 130 km at 48 hr and 147 p,m at 72 hr. By comparison, no outgrowth was seen on the rocky astrocytes after 24 hr, and the median length of the longest neurite was 61 pm at 48 hr and 83 pm at 72 hr. Two points can therefore be made from these graphs: first, both the length of the Total neuritic length (pm) Figure 9 . Neurite outgrowth on astrocyte subpopulations. El5 mesencephalic cells were allowed to extend processes on flat and rocky astrocyte monolayers for 24 hr, 48 hr, or 72 hr. At least 50 neurons with processes greater than one soma diameter were considered for each condition. Distributions of both the length of the longest neurite (A) and the total neuritic length (B) were plotted as a fraction of neurites (vertical axis) at a specific length measured in micrometers (horizontal axis). Both the length of the longest neurite (A).and the total neuritic length (B) were significantly greater on flat astrocytes as compared to rocky astrocytes after each comparable time point (48 or 72 hr) (p < 0.001; Mann-Whitney test).
longest neurite and the total neuritic length increased on flat and rocky substrates during the course of the experiment, demonstrating that the neurites were growing on both kinds of astrocyte. Second, the neurites were shorter on the rocky substrate than on the flat substrate at each time point examined, indicating that rocky astrocytes are a less permissive outgrowth substrate. The fact that the plots are practically superimposable for process extension on the rocky substrate after 48 hr and the flat substrate after 24 hr suggests that outgrowth is initially retarded on rocky astrocytes by approximately 1 d. Neurites then began to grow, but at a slower rate than on flat astrocytes; therefore, some early event in neurite generation may have been inhibited more than Length of longest neurite (urn) Figure   10 . Effects of enzyme treatment on the neurite outgrowth-promoting ability of flat astrocytes. El5 mesencephalic cells were plated onto confluent control (untreated) monolayers or monolayers treated with chondroitinase ABC, chondroitinase AC, heparitinase, or hyaluoronidase. Outgrowth was measured at 24 hr. Distributions of the length of the longest neurite were plotted as in Figure 9 . This parameter was not significantly affected by prior exposure to enzymes.
process outgrowth itself, once established. In other experiments, similar outgrowth values were obtained using El7 cerebral cortical cells instead of El5 mesencephalic cells (data not shown), again suggesting that the different growth promoting abilities of flat and rocky astrocytes are due to astrocytic and not neuronal qualities.
Neurite outgrowth on enzyme-treated astrocytes
To determine if the differential ability of the two astrocyte subpopulations to support neurite outgrowth was correlated with CSPG glycosaminoglycan (GAG) chains, astrocytes were first treated with chondroitinase ABC or AC as described in Materials and Methods. They were also treated with heparitinase and hyaluronidase to investigate the relative contributions of HSPG GAGS and hyaluronic acid. Dissociated El5 mesencephalic cells were plated onto confluent monolayers of enzyme-treated astrocytes and untreated controls, and the extent of neurite outgrowth was determined at 24 and 48 hr. There was no significant difference in the distribution of the length of the longest neurite or the total neuritic length for neurons grown on enzyme-treated flat astrocytes in comparison to controls at either 24 or 48 hr; this is shown in Figure 10 for the length of the longest neurite at 24 hr. These results suggest that chondroitin/heparan sulfate GAGS and hyaluronic acid do not play major roles in regulating neurite outgrowth on flat astrocytes.
On rocky astrocytes, the vast majority of neurons demonstrated no outgrowth after 24 hr; likewise, no outgrowth was seen on rocky astrocytes at 24 hr following heparitinase or hyaluronidase treatment. Heparitinase and hyaluronidase treatment also did not significantly affect outgrowth on rocky astrocytes at 48 hr (data not shown). Early experiments have demonstrated that flat and rocky astrocytes contain similar levels of HSPGs, but that the HSPG levels are quite low in comparison to levels of other neurite outgrowth-promoting molecules such as laminin or fibronectin (data not shown); therefore, the HSPG concentration in the matrix may not be high enough to affect the overall permisivity of the substrate. Total neuritic length (pm) Figure II . Effects of chondroitinase treatment on the neurite outgrowth-promoting ability of rocky astrocytes. El5 mesencephalic cells were plated onto confluent monolayers of flat astrocytes, rocky astrocytes, or rocky astrocytes treated with chondroitinase ABC (ch ABC) or AC (ch AC). Outgrowth was measured at 24 and 48 hr. Box-andwhisker plots show distributions of the length of the longest neurite on each type of substrate. Boxes enclose 25th and 75th percentiles of each distribution and are bisected by the median; whiskers indicate 5th and 95th percentiles. Treatment with either chondroitinase ABC or AC increased neurite outgrowth on rocky astrocytes; however, flat astrocytes are still a more favorable substrate for neurite outgrowth. Figure   12 . Neurite outgrowth on extracellular matrix. El5 mesencephalic cells were plated onto matrix prepared from confluent monolayers of flat or rocky astrocytes and allowed to extend processes for 24 or 24 hr. Box-and-whisker plots show distributions of the total neuritic length on each type of substrate. Neurite outgrowth on intact, living cells was replotted from the data in Figure 9 . Neurite outgrowth on living astrocytes was greater than on corresponding matrix fractions.
at 24 hr, whereas flat matrix did permit outgrowth. Also similar to cells, outgrowth was comparable on rocky matrix at 48 hr and flat matrix at 24 hr, although values were slightly lower (as opposed to nearly identical in the case of cells) on rocky matrix. In this experiment, the length of the longest neurite for neurons grown on matrix and cells followed the same trend as the total neuritic length (data not shown).
Chondroitinase treatment allowed some neurite outgrowth on rocky astrocytes at 24 hr, although it was not as robust as that observed on flat astrocytes. Figure 11 presents a box-and-whisker plot of the lengths of the longest neurite for neurons grown on control and chondroitinase-treated rocky astrocytes; this plot demonstrates that the median length of the longest neurite was 38 pm on chondroitinase ABC-treated astrocytes, 33 pm on chondroitinase AC-treated astrocytes, and 60 pm on flat astrocytes. Growth on rocky astrocytes at 48 hr was similar to growth on flat astrocytes at 24 hr. Neuritic length at 48 hr was increased for neurons growing on chondroitinase ABC or AC-treated rocky astrocytes, but again, the median length of the longest neurite was greatest for neurons grown on flat astrocytes. Longer periods of chondroitinase treatment (up to 10 hr) did not yield any further increases in outgrowth (data not shown). This suggests that CSPG GAGS in the rocky ECM are indeed inhibitory to neurite outgrowth but that they are not the only factor accounting for the differences in flat and rocky astrocytes. The fact that similar results were obtained with either chondroitinase ABC or AC also suggests that DS does not contribute significantly to the rocky phenotype. In this experiment, total neuritic length followed the same trend as the length of the longest neurite (data not shown).
Neurite outgrowth on extracellular matrix
To verify a role for the rocky ECM in the inhibition of neurite outgrowth, dissociated El 5 mesencephalic cells were plated onto matrix prepared from flat and rocky astrocytes and allowed to extend processes for 24 or 48 hr. The extent of neurite outgrowth was then determined. A box-and-whisker plot of the total neurite lengths is shown in Figure 12 ; this plot also incorporates outgrowth data replotted from Figure 9 for neurons grown on intact, living cells. Outgrowth on matrix was similar to outgrowth on intact, living cells in that no outgrowth occurred on rocky matrix Outgrowth was always lower on matrix than on the corresponding living cells; for example, the median total neuritic length for neurons grown on flat matrix for 48 hr was 60 pm (in comparison to 250 pm on flat astrocytes), and the median total neuritic length for neurons grown on rocky matrix for 48 hr was 18 p,rn (in comparison to 115 pm on rocky astrocytes). This suggests that both kinds of cells produce soluble products not found in matrix that stimulate neuronal growth. The difference between cells and matrix was larger for flat astrocytes than for rocky astrocytes (Fig. 12) , which could be interpreted to mean that the former produce a larger ratio of soluble neuriteoutgrowth promoting versus inhibiting factors.
Discussion
Purified populations of rocky and flat astrocytes, following isolation from mixed monolayers, demonstrate significant differences in morphology and functional interactions with neurons. Rocky astrocytes, as well as matrix prepared from these astrocytes, are poor substrates for neuronal adhesion and process outgrowth. Consistent with this data, rocky astrocytes express high levels of tenascin and CS-6-PG, ECM molecules believed to be inhibitory for axon growth, whereas flat astrocytes express low levels of these molecules. Taken together, these properties of rocky astrocytes suggest that they represent a distinct phenotype of type-1 astrocytes.
Previous classifications of cultured astrocytes have depended upon differences in either lineage, cellular morphology or antigenicity. For example, the type-2 astrocyte was distinguished by its stellate, process-bearing morphology and cross-reactivity with the antibody AZBS (Eisenbarth et al., 1979) but not the antibody Ran-2 (Bartlett et al., 1981) ; flat type-l astrocytes, in contrast, reacted with Ran-2 but not A2B5. An additional type of astrocyte, which has a flat, spread morphology with many cytoplasmic processes (Vaysee and Goldman, 1992) has been identified in rat CNS cultures. This astrocyte is antigenically distinct from the type-l astrocyte, in that it binds GD3 ganglioside and may also bind A2B5. Miller and Szigeti (1991) have identified five morphologically distinct astrocyte lineages in spinal cord cultures; each of these lineages displayed heterogeniety in antigenicity toward A2B5 and Ran-2. Similar to these previous classifications, rocky and flat astrocytes can be differentiated morphologically, as well as antigenically by their heterologous expression of ECM molecules. Furthermore, functional assays which demonstrate the restrictive nature of rocky astrocytes toward the growth of CNS neurons provides a new criterion with which to classify cultured astrocytes.
The unequivocal identification of a cultured astrocyte with its in vivo counterpart is dependent upon unique molecular markers. In the absence of such markers, the only data available are correlative. In this vein, both the functional and antigenic properties of rocky astrocytes are reminiscent of glia found in normal boundary regions of the embryonic and early postnatal CNS, such as the developing somatosensory cortical barrel fields (Crossin et al., 1989; Steindler et al., 1989) and the dorsal root entry zone of the spinal cord (Pindzola et al., 1993) . Astrocytes in these regions are characterized by a high expression of tenascin and CSd-PG (Steindler et al., 1989 (Steindler et al., , 1990 Snow et al., 1990b; Pindzola et al., 1993) . High levels of these molecules have also been identified in the neonatal subventricular zone (SVZ) (McKeon et al., 1991; Gates et al. 1995) where they may form boundaries to regulate neuronal migration (Gates et al. 1995) . Because our dissection procedure may include this region, the tenascin/CS-6-PG-rich rocky astrocytes may potentially represent subventricular cells.
Tenascin and CS-6-PG have both been shown to be inhibitory substrates for several types of CNS neurons in vitro (Faissner and Kruse, 1990; Snow et al., 1990a) . Moreover, the combination of tenascin and CS-6-PG has been suggested to be particularly repulsive to neuronal growth and regeneration (Newgreen et al., 1986 (Newgreen et al., , 1990 McKeon et al., 1991) . These molecules are upregulated in response to CNS injury and may contribute to a chemical barrier provided by glial scars (McKeon et al., 1991; Pindzola et al., 1993) . In support of this hypothesis, McKeon and Silver (McKeon and Silver, 1992) have shown that disruption of CS-6-PG on glial scars via chondroitinase treatment creates a more permissive environment for neurite outgrowth. In a similar fashion, chondroitinase treatment increased the ability of rocky astrocytes to promote neurite outgrowth, but not to the extent of flat astrocytes. Therefore, in addition to CSPG GAGS, other molecules expressed by rocky astrocytes must limit neurite outgrowth.
Obvious candidate molecules include tenascin, CSPG core proteins or soluble factors; however, our attempts to alter neurite outgrowth on rocky astrocytes through the use of tenascin antibodies have not been successful. Alternatively, rocky astrocytes may lack positive regulators present in flat astrocytes.
The original identification of the rocky astrocyte as boundaryforming was based on the inability of neurites to cross from flat to rocky regions in mixed cultures (Grierson et al., 1990) . How a neuron reacts to a substrate is strongly dependent upon context. Thus, neurites avoid rocky patches in mixed cultures but will grow on the purified subpopulation. This is similar to neurite outgrowth on glial scars: in vivo, glial scars in the adult mammalian CNS prevent extension of damaged axons, whereas explant cultures of glial scars do permit some growth of embryonic neurites in vitro (McKeon et al., 1991) . Thus, a boundary is created by the apposition of cells with different abilities to promote neuronal migration and neuritic growth. However, not all neurons respond identically to the same cues. For example, embryonic cerebral cortical neurons appear to avoid a CSPG-rich region of the cortical plate, while thalamocortical afferents segregate within this region (Bicknese et al., 1994) .
The complete set of stimuli that induce boundary formation both during development and after injury are as yet unknown. We have previously proposed a major role for cytokines (Meiners et al., 1993) ; for example, basic fibroblast growth factor (bFGF), which is present in high levels during CNS development (Caday et al., 1990; Heuer et al., 1990; Reid et al., 1990) upregulates both tenascin (Meiners et al., 1993 ) and CS-6-PG (our unpublished results) on cultures of neonatal astrocytes. Thus, bFGF may be responsible for the high levels of these proteins found in normal boundary zones. (It should be noted that cultures used in our previous study consisted only of flat astrocytes, and that the observed changes in astrocyte physiology were reversible and dependent on the physical presence of the cytokine: hence, bFGF treatement does not cause a flat astrocyte to "become" a rocky astrocyte.) Basic FGF and other cytokines are again elevated following CNS injury (Finkelstein et al., 1988) , where they may promote the formation of glial scars and the concomitant increase in tenascin and CS-6-PG. On the other hand, only a subpopulation of scar-forming astrocytes express high levels of tenascin in vivo (Laywell et al., 1992) , which implies a heterogeniety in their responsiveness to cytokines. Likewise, the heterogeniety of rocky and flat astrocytes in culture may reflect a differential response to the culture environment.
Finally, the question arises as to whether rocky and flat astrocytes represent different types of glial cells (which would imply an intrinsic difference in genotype or lineage) or different states of the same cell. The data presented within this study support the idea that rocky and flat astrocytes may represent different subtypes of astrocytes, in that subcultured rocky cells breed rocky and flat cells breed flat. We have also noted that the subcultured cells do not change their general morphology even after 34 months in vitro, that is, rocky cells do not become flat and flat cells do not become rocky (unpublished data). The fact that these cultures were neuron-free also eliminates contact with neurons as promoting a change in phenotype. On the other hand, while the low density culture techniques utilized in this study ensured that most of the subcultured flat and rocky cells were plated down as single cells, some of the cells may have remained in contact with one another or in close enough proximity to other cells to provide homotypic epigenetic signalling to maintain a particular phenotype. The question then becomes whether or not an isolated rocky or flat cell will produce a similar rocky or flat daughter cell in the absence of any external environmental cues.
Our initial experiments with single-cell cloning analysis (Temple and Raff, 1986 ) of cerebral cortical astrocytes have revealed cells with several distinct morphologies, including some with a flattened, angular soma ("flat") and others with an elongated, process-bearing soma ("rocky") (unpublished data). These isolated astrocytes give rise to progeny with the same morphology. In addition, we have found that embryonic neurons have a propensity to extend processes on isolated "flat" cells but not on "rocky" cells. While these data also support the hypothesis that flat and rocky astrocytes represent different subtypes of cells, more detailed biochemical analyses and neuronal growth assays will be necessary to ascertain that the single-cell clones do actually correspond to the flat and rocky astrocytes characterized in the current study. Whether distinct subtypes or different states, "rocky" and "flat" astrocytes are unique from one another in their expression of ECM and their ability to support neuronal growth. The inhibitory nature of the rocky astrocytes may be due in part to increased levels of tenascin and CS-6-PG on their surface, or it may be due to other as yet undefined attributes. The ability to grow purified cultures of these astrocytes should facilitate the identification of those molecules that are differentially expressed. Moreover, identification of a unique molecular marker for rocky astrocytes will allow us to test the proposition that rocky astrocytes represent a type of high tenascin/CSd-PG astrocyte which appears during CNS development and is correlated with the maintenance of discrete migration tracts and that a similar kind of astrocyte reappears following injury. As such, rocky astrocytes provide a potentially valuable tool for the elucidation of astrocytic properties that inhibit neuronal growth and regeneration, for the exploration of the relative significance of ECM molecules as opposed to other astrocytic properties in regenerative failure, and for the development of therapies to mitigate reactive gliosis.
